Lithium Clavulanate, also known as Clavulanate Lithium or Lithium Clavulanate CRS, is the lithium salt of clavulanic acid. Clavulanic acid belongs to the beta-lactam class of compounds and is known for its beta-lactamase-inhibiting activity. Lithium Clavulanate is chemically identified as lithium (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate.
Lithium Clavulanate has the molecular formula C₈H₈LiNO₅, a molecular weight of approximately 205.09 g/mol and CAS Number 61177-44-4. It is listed by pharmaceutical reference-standard providers as a USP reference standard and European Pharmacopoeia reference standard.
Lithium Clavulanate contains a clavulanate anion associated with a lithium cation. Its molecular structure includes a beta-lactam ring and a characteristic hydroxyethylidene substituent. The stereochemical configuration is important for identifying the correct compound and distinguishing it from related clavulanate substances.
Published reference-standard information describes the material as a pharmaceutical primary standard. Its physical appearance and handling characteristics should be confirmed from the relevant certificate of analysis and supplier documentation.
Clavulanic acid is known for inhibiting certain beta-lactamase enzymes, which can help protect susceptible beta-lactam antibiotics from enzymatic degradation when used in approved combination products. However, Lithium Clavulanate should not automatically be treated as interchangeable with Potassium Clavulanate, which is a distinct salt used in pharmaceutical formulations.
Lithium Clavulanate is specifically listed in pharmaceutical reference-standard catalogues. Its documented reference-standard role makes it relevant to analytical identification, quality-control procedures and pharmacopoeial testing associated with clavulanate substances. Its listing as a reference standard does not by itself establish that it is an approved commercial API for human or veterinary dosage-form manufacture.
Quality evaluation should establish the identity, stereochemical configuration, assay and impurity profile of the material. Relevant analytical documentation may include the reference-standard certificate, chromatographic purity information, identification data and applicable pharmacopoeial documentation.
Lithium Clavulanate reference-standard listings specify refrigerated storage at approximately 2–8°C. Follow the storage instructions on the current certificate and product label rather than assuming that one storage condition applies to every grade.
1. What is Lithium Clavulanate?
Lithium Clavulanate is the lithium salt of clavulanic acid.
2. What is the CAS number of Lithium Clavulanate?
Its CAS Number is 61177-44-4.
3. What is the molecular formula of Lithium Clavulanate?
Its molecular formula is C₈H₈LiNO₅.
4. What is the molecular weight of Lithium Clavulanate?
Its molecular weight is approximately 205.09 g/mol.
5. What is the chemical category of Lithium Clavulanate?
It is a lithium salt of a beta-lactamase inhibitor compound.
6. What is the pharmaceutical significance of clavulanate?
Clavulanate is known for inhibiting certain beta-lactamase enzymes.
7. Is Lithium Clavulanate the same as Potassium Clavulanate?
No. They are different salts of clavulanic acid and have different counterions and chemical identities.
8. What is the CAS number of Lithium Clavulanate?
The registered CAS Number is 61177-44-4.
9. Is Lithium Clavulanate available as a pharmacopoeial reference standard?
Yes. It is listed in USP and European Pharmacopoeia reference-standard catalogues.
10. What are the important quality tests for Lithium Clavulanate?
Identity, assay, stereochemical identity and related-substance testing are relevant, according to the applicable reference-standard documentation.
11. How should Lithium Clavulanate be stored?
Reference-standard listings specify storage at approximately 2–8°C. Follow the current product label and certificate.
12. Is Lithium Clavulanate interchangeable with commercial clavulanate API?
No. It should not be assumed interchangeable with Potassium Clavulanate or another clavulanate salt without appropriate technical and regulatory documentation.
| Parameter | Specification |
|---|---|
| Appearance | White to almost white crystalline powder |
| Identification | HPLC & IR compliant |
| Assay (HPLC) | 96.5–102.0%* |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.2% |
| Heavy Metals | NMT 20 ppm |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 0.5% |